Hopstaken RM. Antibiotica bij hoestende kinderen. Ned Tijdschr Geneeskd. (accepted)
St John A, Hopstaken RM, Tirimacco R, Audehm R, Price CP. The use of point-of-care testing of CRP for better diagnosis and guiding antibiotic therapy in acute respiratory infections: How can it be implemented? Brit J Gen Pract. 2022; 72 (715): 87-88. DOI: https://doi.org/10.3399/bjgp22X718517.
Loots FJ, Smits M, Hopstaken RM, Jenniskens K, Schroeten Van den Bruel A, van de Pol AC, Oosterheert JJ, Bouma H, Little P, Moore M, van Delft S, Rijpsma D, Holkenborg J, van Bussel BCT, Laven RMJ, Bergmans DJC, Hoogerwerf J, Latten GHP, de Bont E, Giesen P, den Harder A, Kusters R, van Zanten ARH, Verheij TJM. Development and external validation of a new clinical prediction model for early recognition of sepsis in adult patients in primary care: a diagnostic study. Brit J Gen Pract (accepted)
Boere TM, van Buul LW, Hopstaken RM, van Tulder MW, Twisk JWMR, Verheij TJM, Hertogh CMPM. Effect van CRP point-of-care testing op het voorschrijven van antibiotica voor verpleeghuisbewoners met mogelijke lage luchtweginfecties. Ned Tijdschr Geneeskd. (accepted)
Boere TM, van Buul LW, Hopstaken RM, van Tulder MW, Twisk JWMR, Verheij TJM, Hertogh CMPM. Effect of C reactive protein point-of-care testing on antibiotic prescribing for lower respiratory tract infections in nursing home residents: cluster randomised controlled trial. Brit Med J. 2021 Sep 21;374:n2198. doi: 10.1136/bmj.n2198. PMID: 34548288.
Boere TM, Hopstaken RM, van Tulder MW, Schellevis FG, Verheij TJM, Hertogh CMPM, van Buul LW. Implementation and Use of Point-of-Care C-Reactive Protein Testing in Nursing Homes. J Am Med Dir Assoc. 2021 Oct 7:S1525-8610(21)00830-6. doi: 10.1016/j.jamda.2021.09.010.
Heerink JS, Gemen E, Oudega R, Geersing GJ, Hopstaken RM, Kusters R. Performance of C-Reactive Protein, Procalcitonin, TAT Complex, and Factor VIII in Addition to D-Dimer in the Exclusion of Venous Thromboembolism in Primary Care Patients. Lab J Appl Med. 2021 Oct 1:jfab094. doi: 10.1093/jalm/jfab094. Online ahead of print. PMID: 34597379
Price CP, Fay M, Hopstaken RM. Point-of-Care Testing for D-Dimer in the Diagnosis of Venous Thromboembolism in Primary Care: A Narrative Review. Cardiol Ther. 2021 Jun;10(1):27-40. doi: 10.1007/s40119-020-00206-2. Epub 2020 Dec 2
Loots FJ, Smulders D, Giesen P, Hopstaken RM, Smits M. Vital signs of the Systemic Inflammatory Response Syndrome in adult patients with acute infections presenting in out-of-hours primary care: a cross-sectional study. European J General Pract. 2021. 27:1, 83-89, DOI: 10.1080/13814788.2021.1917544
Toorop MMA, Chen Q, Kruip MJHA, van der Meer FJM, Nierman MC, Faber L, Goede L, Cannegieter SC, Lijfering WM. Switching from vitamin K antagonists to direct oral anticoagulants in non-valvular atrial fibrillation patients: Does low time in therapeutic range affect persistence? J Thromb Haemost. 2021 Nov 14. doi: 10.1111/jth.15592.
Hendriks SV, Hout WBVD, van Bemmel T, Bistervels IM, Eijsvogel M, Faber LM, Hofstee HMA, van der Hulle T, Iglesias Del Sol A, Kruip MJHA, Mairuhu ATA, Middeldorp S, Nijkeuter M, Huisman MV, Klok FA; YEARS Investigators. Home Treatment Compared to Initial Hospitalization in Normotensive Patients with Acute Pulmonary Embolism in the Netherlands: A Cost Analysis. Thromb Haemost. 2021 May 26. doi: 10.1055/a-1518-1847.
Veen CSB, Huisman EJ, Romano LGR, Schipaanboord CWA, Cnossen MH, de Maat MPM, Leebeek FWG, Kruip MJHA. Outcome of Surgical Interventions and Deliveries in Patients with Bleeding of Unknown Cause: An Observational Study. Thromb Haemost. 2021 Nov;121(11):1409-1416. doi: 10.1055/s-0041-1726344.
Punt MC, Waning ML, Mauser-Bunschoten EP, Kruip MJHA, Eikenboom J, Nieuwenhuizen L, Makelburg ABU, Driessens MHE, Duvekot JJ, Peters M, Middeldorp JM, Bloemenkamp KWM, Schutgens REG, Lely AT, van Galen KPM. Maternal and neonatal bleeding complications in relation to peripartum management in hemophilia carriers: A systematic review. Blood Rev. 2021 Sep;49:100826. doi: 10.1016/j.blre.2021.100826.
Kruip MJHA, Cannegieter SC, Ten Cate H, van Gorp ECM, Juffermans NP, Klok FA, Maas C, Vonk-Noordegraaf A; Dutch COVID Thrombosis Coalition study group. Caging the dragon: Research approach to COVID-19-related thrombosis. Res Pract Thromb Haemost. 2021 Mar 8;5(2):278-290. doi: 10.1002/rth2.12470.
Dutch COVID & Thrombosis Coalition, Kaptein FHJ, Stals MAM, Grootenboers M, Braken SJE, Burggraaf JLI, van Bussel BCT, Cannegieter SC, Ten Cate H, Endeman H, Gommers DAMPJ, van Guldener C, de Jonge E, Juffermans NP, Kant KM, Kevenaar ME, Koster S, Kroft LJM, Kruip MJHA, Leentjens J, Marechal C, Soei YL, Tjepkema L, Visser C, Klok FA, Huisman MV. Incidence of thrombotic complications and overall survival in hospitalized patients with COVID-19 in the second and first wave. Thromb Res. 2021 Mar;199:143-148. doi: 10.1016/j.thromres.2020.12.019.
Atiq F, Saes JL, Punt MC, van Galen KPM, Schutgens REG, Meijer K, Cnossen MH, Laros-Van Gorkom BAP, Peters M, Nieuwenhuizen L, Kruip MJHA, de Meris J, van der Bom JG, van der Meer FJM, Fijnvandraat K, Kruis IC, van Heerde WL, Eikenboom HCJ, Leebeek FWG, Schols SEM; WiN, RBiN and TiN study groups. Major differences in clinical presentation, diagnosis and management of men and women with autosomal inherited bleeding disorders. EClinicalMedicine. 2021 Jan 29;32:100726. doi: 10.1016/j.eclinm.2021.100726.
Hamulyák EN, Wiegers HMG, Scheres LJJ, Hutten BA, de Lange ME, Timmermans A, Westerweel PE, Nijziel MR, Kruip MJHA, Ten Wolde M, Ypma PF, Klok FA, Nieuwenhuizen L, van Wissen S, Hovens MMC, Faber LM, Kamphuisen PW, Büller HR, Middeldorp S. Heavy menstrual bleeding on direct factor Xa inhibitors: Rationale and design of the MEDEA study. Res Pract Thromb Haemost. 2020 Dec 18;5(1):223-230. doi: 10.1002/rth2.12471.
Atiq F, Wuijster E, de Maat MPM, Kruip MJHA, Cnossen MH, Leebeek FWG. Criteria for low von Willebrand factor diagnosis and risk score to predict future bleeding. J Thromb Haemost. 2021 Mar;19(3):719-731. doi: 10.1111/jth.15227.
Kakkos SK, Gohel M, Baekgaard N, Bauersachs R, Bellmunt-Montoya S, Black SA, Ten Cate-Hoek AJ, Elalamy I, Enzmann FK, Geroulakos G, Gottsäter A, Hunt BJ, Mansilha A, Nicolaides AN, Sandset PM, Stansby G, Esvs Guidelines Committee, de Borst GJ, Bastos Gonçalves F, Chakfé N, Hinchliffe R, Kolh P, Koncar I, Lindholt JS, Tulamo R, Twine CP, Vermassen F, Wanhainen A, Document Reviewers, De Maeseneer MG, Comerota AJ, Gloviczki P, Kruip MJHA, Monreal M, Prandoni P, Vega de Ceniga M. Editor's Choice - European Society for Vascular Surgery (ESVS) 2021 Clinical Practice Guidelines on the Management of Venous Thrombosis.
Schütte LM, van Hest RM, Cnossen MH, Stoof SCM, Leebeek FWG, Mathôt RAA, Kruip MJHA. The association between desmopressin exposure, FVIII response and side effects. Haemophilia. 2021 Jul;27(4):e506-e509. doi: 10.1111/hae.14227.
Preijers T, Schütte LM, Kruip MJHA, Cnossen MH, Leebeek FWG, van Hest RM, Mathôt RAA. Population Pharmacokinetics of Clotting Factor Concentrates and Desmopressin in Hemophilia. Clin Pharmacokinet. 2021 Jan;60(1):1-16. doi: 10.1007/s40262-020-00936-5.
T H Geersing, E J F Franssen, P E Spronk, H J M van Kan, M den Reijer, P H J van der Voort Nephrotoxicity of continuous amphotericin B in critically ill patients with abdominal sepsis: a retrospective analysis with propensity score matching. J Antimicrob Chemother. 2021 Oct 6;dkab372.
Antoni P. A. Hendrickx, Fabian Landman, Angela de Haan, Sandra Witteveen, Marga G. van Santen-Verheuvel, Leo M. Schouls, and the Dutch CPE surveillance Study Group. bla OXA-48-like genome architecture among carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in the Netherlands. Microb Genom. 2021; 7(5): 000512.
Bins JE, Metting EI, Muilwijk-Kroes JB, Kocks JW, In ‘t Veen JC. De histamineprovocatietest voor astma kan ook in de eerste lijn. Huisarts Wet 2021;64:DOI:10.1007/s12445-021-1265-1.